Results 21 to 30 of about 247,170 (323)
Choroidal metastasis in pancreatic adenocarcinoma
Journal of Cancer Research and Therapeutics, 2022 Pancreatic adenocarcinoma is the seventh largest cause of death from cancer with a death rate of 3.8%. The 5-year survival rate is only 5%. We report A case 28 year old male presented with a 3 week history of pain in upper part of abdomen and dyspepsia of similar duration. After 2 cycles of palliative chemotherapy he presented with diminution of vision
Ashok, Singh +3 more
openaire +2 more sources
Neuroblastoma with ovarian and pancreatic metastasis
Journal of Pediatric Surgery Case Reports, 2021 Neuroblastoma metastasis to the pancreas and ovaries is rare. We report a 12-year-old girl diagnosed with primary left adrenal neuroblastoma and metastases to the local lymph nodes, left orbit, left ovary, and multiple bones. After 4 courses of chemotherapy, the orbital and bone metastases disappeared; the ovarian tumor remained and the lymph node ...
Seisho Sakai +10 more
openaire +3 more sources
BMC Nursing, 2023 Background Clinical nurses are susceptible to compassion fatigue when exposed to various types of traumatic events in patients for extended periods of time.
Jie Zhang +6 more
doaj +1 more source
PANCREATIC ADENOCARCINOMA WITH PENILE METASTASIS [PDF]
Journal of Cancer & Allied Specialties, 2017 -
Julie I Woods +3 more
openaire +2 more sources
CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. [PDF]
PLoS ONE, 2016 Tumor metastasis is driven by malignant cells and stromal cell components of the tumor microenvironment. Cancer stem cells (CSCs) are thought to be responsible for metastasis by altering the tumor microenvironment. Epithelial-mesenchymal transition (EMT)
Lirong Zhang +10 more
doaj +1 more source
Epigenetic control of pancreatic cancer metastasis
Cancer and Metastasis Reviews, 2023 AbstractSurgical resection, when combined with chemotherapy, has been shown to significantly improve the survival rate of patients with pancreatic ductal adenocarcinoma (PDAC). However, this treatment option is only feasible for a fraction of patients, as more than 50% of cases are diagnosed with metastasis.
Krauß, Lukas +4 more
openaire +3 more sources
Invasion and metastasis in pancreatic cancer.
Molecular cancer, 2003 Pancreatic cancer remains a challenging disease with an overall cumulative 5-year survival rate below 1%. The process of cancer initiation, progression and metastasis is still not understood well. Invasion and tumor metastasis are closely related and both occur within a tumour-host microecology, where stroma and tumour cells exchange enzymes and ...
Roman Ludwig +4 more
openaire +4 more sources
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. [PDF]
, 2018 Expression of the chromatin-associated protein HMGA2 correlates with progression, metastasis and therapy resistance in pancreatic ductal adenocarcinoma (PDAC). Hmga2 has also been identified as a marker of a transient subpopulation of PDAC cells that has
Chiou, Shin-Heng +7 more
core +1 more source
Pancreatic Metastasis from Prostate Cancer [PDF]
Case Reports in Medicine, 2010 The pancreas is an unusual location for metastases from other primary cancers. Rarely, pancreatic metastases from kidney or colorectal cancers have been reported. However, a variety of other cancers may also spread to the pancreas. We report an exceptional case of pancreatic metastasis from prostate cancer. Differences in management between primary and
Sylvestre Le Moulec +7 more
openaire +4 more sources
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management. [PDF]
, 2017 Pancreatic cancer is one the most lethal malignancies. Only a small proportion of patients with this disease benefit from surgery. Chemotherapy provides only a transient benefit.
Michael Pimienta +4 more
core +2 more sources